Skip to main content
About
Contact
Subscribe
e-Edition
Make Home Page
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Twitter
Toggle navigation
Site search
Search
Home
Contact Us
Advertise
Subscription Services
Promote Your Event
Submission Forms
News
Local News
National
World
Archives
Sports
Local Sports
National Sports
Business
Local Business
National Business
Technology
Markets & Stocks
Opinion
Columns
Editorials
Letters To The Editor
Polls
Thumbs
A & E
Local Entertainment
Art Scene
Music Scene
Theatre Scene
Book Reviews
Movie Reviews
TV Listings
Local Events
What To Do
Life
Health
Travel
Oddities
Community Directory
Community Service
Rescue Me
Other
Specials
Spring Home & Garden Show
Home & Realty
Outdoor Guide
Women
Spring on the Road
Spring Wellness
Premier Home Stylle Tour 2024
Classifieds
Place Ad
Careers
Tenders
Weather
Obituaries
Parcel Pickup
2024 Readersâ Choice
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Gritstone Bio Inc
(NQ:
GRTS
)
0.0322
UNCHANGED
Last Price
Updated: 4:00 PM EDT, Oct 21, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Gritstone Bio Inc
< Previous
1
2
3
4
5
6
7
Next >
12 Health Care Stocks Moving In Monday's Intraday Session
October 21, 2024
Via
Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
October 21, 2024
Via
Benzinga
Why TSMC Shares Are Trading Higher By Around 8%; Here Are 20 Stocks Moving Premarket
October 17, 2024
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
October 15, 2024
Via
Benzinga
Why Gritstone Bio (GRTS) Stock Is Down 64% Today
October 10, 2024
Gritstone bio shares are trading lower by 65% during Thursday's session. The company announced it voluntarily filed for Chapter 11 restructuring.
Via
Benzinga
Key Takeaways From Gritstone Bio Analyst Ratings
October 01, 2024
Via
Benzinga
Where Gritstone Bio Stands With Analysts
August 05, 2024
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
October 15, 2024
Via
Benzinga
Why Ericsson Shares Are Trading Higher By Around 9%; Here Are 20 Stocks Moving Premarket
October 15, 2024
Via
Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
October 14, 2024
Via
Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
October 14, 2024
Via
Benzinga
Why Aehr Test Systems Shares Are Trading Higher By Around 14%; Here Are 20 Stocks Moving Premarket
October 11, 2024
Via
Benzinga
S&P Moves Lower; Domino's Pizza Posts Mixed Q3 Results
October 10, 2024
Via
Benzinga
Topics
Stocks
Exposures
US Equities
12 Health Care Stocks Moving In Thursday's Intraday Session
October 10, 2024
Via
Benzinga
Crude Oil Surges 3%; Delta Air Lines Posts Downbeat Earnings
October 10, 2024
Via
Benzinga
Exposures
Fossil Fuels
Dow Falls Over 100 Points; US Inflation Rate Slows To 2.4% In September
October 10, 2024
Via
Benzinga
Topics
Economy
Stocks
Exposures
Interest Rates
US Equities
12 Health Care Stocks Moving In Thursday's Pre-Market Session
October 10, 2024
Via
Benzinga
Gritstone bio Takes Action to Preserve Value and Strengthen Capital Structure
October 10, 2024
From
Gritstone bio, Inc.
Via
Business Wire
12 Health Care Stocks Moving In Tuesday's After-Market Session
October 01, 2024
Via
Benzinga
Penny Stock Gritstone Bio Hires Advisor To Evaluate Options, Analyst Downgrades Stock As Data 'Insufficient To Excite Many Investors'
October 01, 2024
Gritstone Bio's Phase 2 data for GRANITE in MSS-CRC shows promising results, including a 38% risk reduction for patients with low ctDNA. Gritstone plans to review the data with the FDA for potential...
Via
Benzinga
Exposures
Product Safety
12 Health Care Stocks Moving In Tuesday's Intraday Session
October 01, 2024
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
October 01, 2024
Via
Benzinga
Gritstone bio Announces Interim Phase 2 Data for GRANITE Individualized Neoantigen Targeting Immunotherapy in Frontline Metastatic Microsatellite Stable Colorectal Cancer
September 30, 2024
From
Gritstone bio
Via
GlobeNewswire
GRTS Stock Earnings: Gritstone Bio Beats EPS, Misses Revenue for Q2 2024
August 13, 2024
GRTS stock results show that Gritstone Bio beat analyst estimates for earnings per share but missed on revenue for the second quarter of 2024.
Via
InvestorPlace
Gritstone bio Reports Second Quarter 2024 Financial Results and Provides Corporate Updates
August 13, 2024
From
Gritstone bio
Via
GlobeNewswire
GRITSTONE ALERT: Bragar Eagel & Squire, P.C. is Investigating Gritstone bio, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
August 07, 2024
From
Bragar Eagel & Squire
Via
GlobeNewswire
GRTS Investors Have Opportunity to Join Gritstone bio, Inc. Fraud Investigation with the Schall Law Firm
August 06, 2024
From
The Schall Law Firm
Via
Business Wire
GRTS Deadline: Rosen Law Firm Urges Gritstone bio, Inc. (NASDAQ: GRTS) Stockholders with Large Losses to Contact the Firm for Information About Their Rights
August 05, 2024
From
The Rosen Law Firm, P.A.
Via
Business Wire
GRTS Investors Have Opportunity to Join Gritstone bio, Inc. Fraud Investigation with the Schall Law Firm
August 05, 2024
From
The Schall Law Firm
Via
Business Wire
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Scotts, Gritstone, Fat Brands, and Charge and Encourages Investors to Contact the Firm
August 02, 2024
From
Bragar Eagel & Squire
Via
GlobeNewswire
< Previous
1
2
3
4
5
6
7
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.